Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.

Peter T. Masiakos(Massachusetts General Hospital), Patricia K. Donahoe(Harvard University), Jose M. Teixeira(Grand Rapids Community College), David Dombkowski(Harvard University Press), Mary Kenneally(Harvard University), Paresh C. Shah(Harvard University Press), Shyamala Maheswaran(Massachusetts General Hospital), Frederic I. Preffer(Massachusetts General Hospital), David J. Kehas(Harvard University Press), Thanh U. Ha(Harvard University), Arlan F. Fuller(Harvard University Press), David T. MacLaughlin(Harvard University)
PubMed
November 1, 1999
Cited by 122

Related Papers

Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
|Cell|2010|2.8k
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
|Proceedings of the National Academy of Sciences|2010|1.6k